Naga MounikaDrug Product · Validation · CMC
Menu
Working document

CCIT Result Investigation and Artifact Decision Plan

A plug-and-play plan for agreeing, before a real CCIT failure happens, the pre-authorized sequence for ruling an artifact in or out before a borderline or failing result is treated as a true leak, with a conservative default for genuine ambiguity and a filled specimen.

Document typePlan
Topic areaDrug Product
LevelAdvanced
UpdatedOctober 2026
How to use this document

Copy the template below into your quality system. Replace every <<FILL: ...>> placeholder with your company, system, and process specifics, then route it through your own document control, review, and approval. The filled specimen shows one worked example; adapt the numbers and scope to your operation and verify each cited regulation or standard against the current source before you rely on it.

This is a generic, originally worded starting point. It contains no confidential, proprietary, or employer material, it is drafted with AI assistance and reviewed, it is not legal or compliance advice, and adopting it does not by itself create or prove compliance. See the Disclaimer and Terms.

This is a ready-to-use plan for agreeing, before a real CCIT failure happens, the sequence used to decide whether a borderline or failing result is a true leak or a test artifact. Complete it during method validation or CCIT protocol drafting so the investigation logic exists before anyone is deciding under schedule pressure with a real result and a batch sitting in the warehouse. Replace every <<FILL: ...>> placeholder with your own specifics and route it through your normal document control, review, and approval. A worked filled specimen follows.

Document control header

FieldEntry
Document titleCCIT Result Investigation and Artifact Decision Plan for <<FILL: method / product / container system>>
Document number<<FILL: e.g. PLN-CCIT-003>>
Version<<FILL>>
Effective date<<FILL>>
Linked CCIT study protocol<<FILL: ref>>
Linked system suitability log<<FILL: ref>>
Document owner<<FILL: e.g. Analytical / Packaging SME>>

1. Purpose

This plan states, with a pre-agreed sequence, how a borderline or failing CCIT result is investigated before it is classified as a true leak or as a test artifact, and what happens to the result, and to units tested around it, at each step of that sequence.

2. Scope

DimensionDecision
CCIT method(s) in scope<<FILL>>
Container closure system(s)<<FILL>>
Does the validated method pre-authorize a retest under confirmed-correct conditions?<<FILL: Yes/No; if Yes, cite the validated method section>>
Out of scope<<FILL: e.g. the full deviation or OOS investigation procedure itself once a true result is confirmed, covered under the site's own procedure>>

3. Responsibilities

RoleResponsibility
CCIT operatorStops and reports a borderline or failing result immediately, without pre-judging whether it is an artifact
Analytical / packaging SMEWorks the artifact-check sequence below and documents each step’s outcome
Quality AssuranceApproves the final classification and disposition; owns the conservative default for genuinely ambiguous cases

4. Artifact-check sequence

Work these checks in order for every borderline or failing result. Do not skip ahead to a retest before the earlier checks are documented.

StepCheckEvidence requiredOutcome if confirmed
1System suitability bracketing this resultReference to the bracketing log entry immediately before and after the suspect resultIf the bracket itself failed, the instrument, not the unit, is the probable cause; investigate per the system suitability log’s escalation rule before proceeding
2Fixture seating and alignmentDocumented check against the qualified fixture geometry (cryobag restraint, PFS dual-seal scan fixture, or equivalent)If misseated, re-seat correctly and retest only if the validated method pre-authorizes it
3Thermal equilibrationConfirmation the unit reached the qualified test temperature before testing, with a time/temperature recordIf not equilibrated, equilibrate and retest only if the validated method pre-authorizes it
4Residual surface moisture or condensationVisual or documented check for condensation, particularly on a unit moved from refrigerated or frozen storageIf present, dry per a documented procedure and retest only if the validated method pre-authorizes it
5Pre-authorized retest, if all of steps 1 to 4 are resolved and the validated method permits itRetest result on the same unit under confirmed-correct conditionsA reproduced result after this point is a true result, not an artifact

5. Decision rule

SituationClassificationDisposition
An artifact source in steps 1 to 4 is confirmed with documented evidence, and the retest (where authorized) passesArtifact, not a true leakOriginal result voided per the documented artifact; unit released per the retest result
No artifact source is confirmed, or the result reproduces after a pre-authorized retestTrue resultHandled under the site’s deviation or OOS investigation procedure; not dispositioned here
Genuinely ambiguous after working the full sequenceTrue result (conservative default)Handled under the site’s deviation or OOS investigation procedure until the investigation resolves it

The sequence in section 4 is not an opportunity to propose a plausible-sounding explanation and stop; every step claimed as the cause has to carry documented evidence, not an assertion.

6. Escalation and documentation

StepRequirement
Initial reportCCIT operator reports any borderline or failing result the same session, before proceeding to further testing
Sequence execution and sign-offAnalytical / packaging SME documents the outcome of each step in section 4, dated
Final classificationQuality Assurance approves the classification and disposition, citing the specific step(s) that resolved it
RecordClassification, evidence, and disposition recorded in <<FILL: investigation log / eQMS reference>>, cross-referenced to the batch or stability record affected

7. Conclusion

FieldEntry
Artifact-check sequence finalized and linked to the CCIT method<<FILL: Yes/No>>
Approved by (QA, name, date)<<FILL>>

8. References

USP General Chapter <1207>, Package Integrity Evaluation, General Considerations. 21 CFR 211.192, review and investigation of an unexplained discrepancy. See the paired article, building a container closure integrity program under USP <1207>, for the reasoning behind this sequence and the specific CCIT artifact sources it addresses. The paired CCIT system suitability verification log for the bracketing evidence step 1 relies on.

9. Revision history

VersionDateAuthorSummary of change
<<FILL: 1.0>><<FILL>><<FILL>>Initial issue.

10. Approvals

RoleNameSignatureDate
Author (Analytical / Packaging)<<FILL>>
Reviewer (Fill-Finish Operations)<<FILL>>
Approver (QA)<<FILL>>

Filled specimen

Extract for a vacuum decay CCIT method on a lyophilized biologic vial, validated method permitting one pre-authorized retest per unit under confirmed-correct conditions.

A stability-pull unit read a pressure rise just past the acceptance threshold. Working the sequence: step 1, the system suitability bracket on either side of this unit both passed, ruling out an instrument-wide cause; step 2, fixture seating was not applicable (rigid vial, no restraint fixture); step 3, the unit had been removed from 2 to 8 degrees C storage and tested 4 minutes after removal, short of the method’s 15-minute equilibration requirement; step 4, no visible condensation was noted but was not separately documented at the time, a gap flagged for the method’s retest record going forward. The unit was re-equilibrated for the full 15 minutes and retested: the repeat result passed well inside the acceptance range. Classification: artifact, incomplete thermal equilibration, confirmed by documented equilibration time and a passing retest; original result voided per this plan, unit released on the retest result. QA approval cited step 3 as the specific resolving evidence.

Common inspection findings this plan prevents

  • A borderline result dispositioned as passing on a proposed artifact, residual moisture or a cold unit, that was never actually confirmed with documented evidence.
  • A retest performed with no pre-authorization in the validated method, amounting to an undocumented quiet retest.
  • An investigation sequence invented in the moment rather than worked against a pre-agreed order, producing inconsistent classifications for similar results over time.
  • A genuinely ambiguous result resolved in the direction that avoids an investigation rather than the conservative default.

How to adapt this plan

  1. Confirm in section 2 whether your validated method actually pre-authorizes a retest; if it does not, strike step 5 and route every borderline or failing result directly to deviation or OOS investigation.
  2. Set the artifact-check sequence in section 4 to match this specific method’s real failure modes; a method with no fixture, for example, can remove step 2 rather than carry an inapplicable row.
  3. Train CCIT operators on the sequence before a real failure happens, not as a procedure read for the first time during one.
  4. Route every classification through Quality Assurance approval; never let an artifact classification stand on the operator’s or SME’s documentation alone.
Add this site to your home screen Full screen, works offline, one tap from your home screen.